Skip to content
sellModerate cluster of 10

Mary C Beckerle sold $426k of EXEL

director at EXELIXIS, INC.. 12,210 shares at an average of $34.88, traded Feb 14, 2025, filed Feb 19, 2025.

Warning score
42
Value
$426k
12,210 shares
Holdings after
30,406
-29% from before
From 52-week low
+38%
low $25.39, close $35.00
From 52-week high
-6%
high $37.27, as of Feb 14, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $426k at market
    +17
  • Share of holdings sold
    Sold 29% of holdings
    +10
  • Cluster
    10 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

EXELOct 9, 2026 · close 59.86
Since filing Feb 19, 2025: +70.7%SPY +29.5% · excess +41.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000939767-25-000027, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 14, 2025MOption exercise
Common Stock
+8,354$23.24$194k42,616Feb 19, 2025
Feb 14, 2025SOpen-market sale
Common Stock
-8,354$34.87$291k34,262Feb 19, 2025
Feb 14, 2025SOpen-market sale
Common Stock
-3,856$34.90$135k30,406Feb 19, 2025
Feb 14, 2025MOption exercise
Option (right to buy)derivative
-8,354$0.00$022,494Feb 19, 2025

Related signals

Other insiders at EXELIXIS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
2Weak
EXELsell10b5-1
EXELIXIS, INC.
Dana Aftab
CSO/EVP Disc & Trans Research
$59k
1,508 shares
-0%
26Weak
EXELsell 610b5-1
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$388k
10,000 shares
-3%
10Weak
EXELsell 1010b5-1
EXELIXIS, INC.
Jack L Wyszomierski
director
$331k
8,768 shares
-2%
60Notable
EXELsell 10
EXELIXIS, INC.
Julie Smith
director
$2.8M
73,808 shares
-113%
55Moderate
EXELsell 10
EXELIXIS, INC.
Dana Aftab
CSO/EVP Disc & Trans Research
$992k
26,987 shares
-5%
47Moderate
EXELsell 10
EXELIXIS, INC.
Christopher J. Senner
EVP and CFO
$1.1M
29,314 shares
-4%
46Moderate
EXELsell 10
EXELIXIS, INC.
Bob Oliver
director
$695k
18,647 shares
-36%
60Notable
EXELsell 10
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$1.9M
52,636 shares
-15%
21Weak
EXELsell 1010b5-1
EXELIXIS, INC.
Sue Gail Eckhardt
director
$405k
11,568 shares
-28%
50Moderate
EXELsell 10
EXELIXIS, INC.
Maria C Freire
director
$1.5M
44,114 shares
-33%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.